Hongfei Ji
Harbin Medical University(CN)Yantai University(CN)Heilongjiang Academy of Sciences(CN)Third Affiliated Hospital of Harbin Medical University(CN)Yantai Academy of Agricultural Sciences(CN)First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Lymphoma Diagnosis and Treatment, Epigenetics and DNA Methylation, Immune Cell Function and Interaction
Most-Cited Works
- → Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer(2019)227 cited
- → FoxO1 Promotes Mitophagy in the Podocytes of Diabetic Male Mice via the PINK1/Parkin Pathway(2017)141 cited
- → Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer(2011)129 cited
- → GLUT1 participates in tamoxifen resistance in breast cancer cells through autophagy regulation(2020)68 cited
- → MicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPARγ and its In Vivo Knockdown Prevents Progression of Diabetic Nephropathy(2016)64 cited
- → Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization(2021)61 cited